The Walsall Healthcare NHS Trust is a public sector healthcare provider in Walsall, West Midlands, England. It originated as Walsall Hospital NHS Trust in December 1990, and was renamed in April 2011 after a merger by acquisition of the Walsall Community Health NHS Trust.

During the past decade, Walsall Manor Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Walsall Manor Hospital" #1 sponsor was "Medical Research Council" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "University College, London" with 2 trials sponsored and "Arthrex, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Walsall Manor Hospital" #1 collaborator was "Barts and the London School of Medicine and Dentistry" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "LifeCell" with 1 trials as a collaborator and "Medical Research Council" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Walsall Manor Hospital" are "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Lung Cancer" (2 trials), "Metastatic Cancer" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Walsall Manor Hospital" in a lesser frequency.

Most popular intervention types in "Walsall Manor Hospital" are "Drug" (15 trials), "Procedure" (9 trials), "Radiation" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (4 trials), "capecitabine" (3 trials), "carboplatin" (3 trials), "fluorouracil" (3 trials) and "quality-of-life assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Walsall Manor Hospital" are 15 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Walsall Manor Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Walsall Manor Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Walsall Manor Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".